​Replacing a defective gene via AAV mediated gene therapy is a powerful therapeutic approach. This project will develop and test safer gene therapy approaches in pre-clinical human brain organoid models.

For those interested in: stem cell ageing and regenerative engineering

You will be studing in the Wolvetang Group.

To apply for this opportunity, please email Professor Wolvetang with the name of the project you are interested in and your CV.

  Are you interested in a PhD at the AIBN? Click here, and start your journey today.